Novel Chlamydia trachomatis Strains in Heterosexual Sex Partners, Indianapolis, Indiana, USA - Volume 20, Number 11—November 2014 - Emerging Infectious Disease journal - CDC
Volume 20, Number 11—November 2014
Research
Novel Chlamydia trachomatis Strains in Heterosexual Sex Partners, Indianapolis, Indiana, USA
On This Page
Byron E. Batteiger1, Raymond Wan, James A. Williams, Linda He, Arissa Ma, J. Dennis Fortenberry, and Deborah Dean1
Abstract
Chlamydia trachomatis causes a high number of sexually transmitted infections worldwide, but reproducible and precise strain typing to link partners is lacking. We evaluated multilocus sequence typing (MLST) for this purpose by detecting sequence types (STs) concordant for the ompA genotype, a single-locus typing standard. We tested samples collected during April 2000–October 2003 from members of established heterosexual partnerships (dyads) in the Indianapolis, Indiana, USA, area who self-reported being coital partners within the previous 30 days. C. trachomatis DNA from 28 dyads was tested by MLST; sequences were aligned and analyzed for ST and phylogenetic relationships. MLST detected 9 C. trachomatis STs, 4 unique to Indianapolis; STs were identical within each dyad. Thirteen unique strains were identified; 9 (32%) dyads harbored novel recombinant strains that phylogenetically clustered with strains comprising the recombinants. The high rate of novel C. trachomatis recombinants identified supports the use of MLST for transmission and strain diversity studies among at-risk populations.
Chlamydia trachomatis, a bacterium that can infect both men and women, is most commonly sexually transmitted. In 2008, approximately 105.7 million new C. trachomatis sexually transmitted infections (STIs) occurred worldwide (1); an estimated 2.86 million incident cases occurred in the United States (2). The last surveillance study of STIs in the United States, in 2011, reported 1,412,791 chlamydial infections, the largest case number for any disease ever reported to the Centers for Disease Control and Prevention (3).
C. trachomatis infections in men and women are mostly asymptomatic; thus, continued sexual activity among persons unaware of their infection status facilitates further transmission. Gaps in knowledge of chlamydial STIs include how measures of immunity, bacterial load, condom use, and other factors relate to transmission risk. Longitudinal studies of these factors are needed to inform treatment and prevention strategies (4). The tools required include careful ascertainment of sexual history and behavioral determinants and reproducible and discriminating biomarkers to strengthen the case for transmission between sex partners linked by partner tracing.
The standard biomarker for these studies is ompA genotyping, but this method lacks precision because the gene is under immune selection and represents only 0.1% of the genome. Because large-scale whole-genome sequencing of clinical samples is not yet feasible, multilocus sequence typing (MLST) for C. trachomatis has been developed to provide greater insight into strain types; 3 such MLST methods have been reported in the literature (5–10). The scheme we developed, on the basis of analysis of 19 reference strains and 68 geographically diverse clinical isolates, identified 44 MLST sequence types (STs), compared with only 20 ompA genotypes (11). In our scheme, we were also able to discriminate single-nucleotide polymorphisms (SNPs) that correlate with disease phenotypes attributable to C. trachomatis: lymphogranuloma venereum (LGV), trachoma, and non-LGV urogenital diseases (11). Our scheme has since been expanded to encompass 192 geographically and clinically diverse samples.
For this study, we applied our MLST scheme to a subset of a well-defined heterosexual partnership (dyad) cohort in Indianapolis, Indiana, USA, comprising 28 dyads for which concordance of the ompA genotype existed between partners. The purpose of the study was to determine whether MLST, which provides a more detailed level of strain typing than ompA genotyping, would also show strain concordance between partners, as would be expected if transmission had occurred within the dyads. In addition, we sought to identify additional C. trachomatis strain types, beyond those identified by ompAgenotyping, that might be unique to Indianapolis, because this geographic region has not previously been included in any MLST database.
Dr Batteiger is an academic infectious diseases physician in the Division of Infectious Diseases, Department of Medicine, and Department of Microbiology and Immunology at Indiana University School of Medicine. His research interests are the epidemiology and molecular epidemiology of C. trachomatis and other sexually transmitted infections in the context of longitudinal studies of high-risk adolescents and infection concordance in partnerships.
Acknowledgments
We thank James Rothschild for excellent technical support.
This work was supported in part by Public Health Service grants from the National Institutes of Health (R01 AI098843 to D.D. and U19 AI31494 to J.D.F. and B.E.B.) and a grant from the Centers for Disease Control and Prevention (UR3/CCU5516481 to B.E.B.).
References
- World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections—2008. World Health Organization, Department of Reproductive Health and Research; 2012 [cited 2014 Mar 30].http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/index.html
- Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Sexually transmitted infections among US women and men: prevalence and incidence estimates—2008. Sex Transm Dis. 2013;40:187–93. DOIPubMed
- Centers for Disease Control and Prevention. Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Sexually transmitted disease surveillance 2011. Atlanta (GA): US Department of Health and Human Services; 2012.
- Gottlieb SL, Martin DH, Xu F, Byrne GI, Brunham RC. Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis. 2010;201(Suppl 2):S190–204. DOIPubMed
- Klint M, Fuxelius HH, Goldkuhl RR, Skarin H, Rutemark C, Andersson SG, High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol. 2007;45:1410–4. DOIPubMed
- Somboonna N, Wan R, Ojcius DM, Pettengill MA, Joseph SJ, Chang A, Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages. MBio. 2011;2:e00045–11. DOIPubMed
- Pannekoek Y, Morelli G, Kusecek B, Morre SA, Ossewaarde JM, Langerak AA, Multi locus sequence typing of Chlamydiales: clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol. 2008;8:42. DOIPubMed
- Christerson L, Bom RJ, Bruisten SM, Yass R, Hardick J, Bratt G, Chlamydia trachomatis strains show specific clustering for men who have sex with men compared to heterosexual populations in Sweden, the Netherlands, and the United States. J Clin Microbiol. 2012;50:3548–55. DOIPubMed
- Gravningen K, Christerson L, Furberg AS, Simonsen GS, Odman K, Stahlsten A, Multilocus sequence typing of genital Chlamydia trachomatis in Norway reveals multiple new sequence types and a large genetic diversity. PLoS ONE. 2012;7:e34452. DOIPubMed
- Bom RJ, van der Helm JJ, Schim van der Loeff MF, van Rooijen MS, Heijman T, Matser A, Distinct transmission networks of Chlamydia trachomatis in men who have sex with men and heterosexual adults in Amsterdam, The Netherlands. PLoS ONE. 2013;8:e53869. DOIPubMed
- Dean D, Bruno WJ, Wan R, Gomes JP, Devignot S, Mehari T, Predicting phenotype and emerging strains among Chlamydia trachomatis infections.Emerg Infect Dis. 2009;15:1385–94. DOIPubMed
- Khan A, Fortenberry JD, Juliar BE, Tu W, Orr DP, Batteiger BE. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Transm Dis. 2005;32:260–4. DOIPubMed
- Stothard DR, Boguslawski G, Jones RB. Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun. 1998;66:3618–25 .PubMed
- Batteiger BE, Tu W, Ofner S, Van Der Pol B, Stothard DR, Orr DP, Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis. 2010;201:42–51. DOIPubMed
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol.2007;24:1596–9. DOIPubMed
- Jolley KA, Wilson DJ, Kriz P, McVean G, Maiden MC. The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol. 2005;22:562–9. DOIPubMed
- Levene H. Robust Tests for Equality of Variances. In: Olkin I, editor. Contributions to probability and statistics: essays in honor of Harold Hotelling. Stanford (CA): Stanford University Press; 1960. p. 278–92.
- Ward ME, Treharne JD, Murray A. Antibody specificity of human antibody to Chlamydia in trachoma and lymphogranuloma. J Gen Microbiol.1986;132:1599–610 .PubMed
- Korhonen S, Hiltunen-Back E, Puolakkainen M. Genotyping of Chlamydia trachomatis in rectal and pharyngeal specimens: identification of LGV genotypes in Finland. Sex Transm Infect. 2012;88:465–9. DOIPubMed
- Fieser N, Simnacher U, Tausch Y, Werner-Belak S, Ladenburger-Strauss S, von Baum H, Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany. Infection. 2013;41:159–66. DOIPubMed
- Machado AC, Bandea CI, Alves MF, Joseph K, Igietseme J, Miranda AE, Distribution of Chlamydia trachomatis genovars among youths and adults in Brazil. J Med Microbiol. 2011;60:472–6. DOIPubMed
- Wang Y, Skilton RJ, Cutcliffe LT, Andrews E, Clarke IN, Marsh P. Evaluation of a high resolution genotyping method for Chlamydia trachomatis using routine clinical samples. PLoS ONE. 2011;6:e16971. DOIPubMed
- Millman KL, Tavare S, Dean D. Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism. J Bacteriol. 2001;183:5997–6008. DOIPubMed
- Jeffrey BM, Suchland RJ, Quinn KL, Davidson JR, Stamm WE, Rockey DD. Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect Immun. 2010;78:2544–53. DOIPubMed
- Gomes JP, Bruno WJ, Nunes A, Santos N, Florindo C, Borrego MJ, Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res. 2007;17:50–60. DOIPubMed
- Millman K, Black CM, Johnson RE, Stamm WE, Jones RB, Hook EW, Population-based genetic and evolutionary analysis of Chlamydia trachomatisurogenital strain variation in the United States. J Bacteriol. 2004;186:2457–65. DOIPubMed
Figures
Table
Technical Appendix
Suggested citation for this article: Batteiger BE, Wan R, Williams JA, He L, Ma A, Fortenberry JD, et al. Novel Chlamydia trachomatis strains in heterosexual sex partners, Indianapolis, Indiana, USA. Emerg Infect Dis [Internet]. 2014 Nov [date cited]. http://dx.doi.org/10.3201/eid2011.140604
1These authors contributed equally to this article.
No hay comentarios:
Publicar un comentario